Literature DB >> 16243223

Macrophagic myofasciitis in childhood: a controversial entity.

Eloy Rivas1, Mercedes Gómez-Arnáiz, Jose R Ricoy, Fernando Mateos, Rogelio Simón, Juan J García-Peñas, Maria T Garcia-Silva, Elena Martín, María Vázquez, Ana Ferreiro, Ana Cabello.   

Abstract

Macrophagic myofasciitis is an unusual inflammatory myopathy, which has been almost exclusively reported in French adults with diffuse arthromyalgias and asthenia. It is characterized by an infiltrate of densely packed macrophages, with granular periodic-acid-Schiff positive content, on muscle biopsies at the site of vaccination. The presence of aluminum inclusions in these macrophages points to an inappropriate reaction to aluminum used as an adjuvant in some vaccines. Although in adults this entity is well defined, less than 15 cases have been reported in children. This study describes seven children, younger than 3 years of age, with typical lesions of macrophagic myofasciitis on quadriceps muscle biopsy. In five cases, biopsies were performed to exclude mitochondrial pathology. All the children developed hypotonia and motor or psychomotor delay, associated with others symptoms. Abnormal neuroimaging was evident in six cases. Spectrometry studies detected elevated levels of aluminum in muscle in three of four cases tested. Despite the wide use of vaccines in childhood, macrophagic myofasciitis was rarely observed in children and its characteristic histologic pattern could not be correlated with a distinctive clinical syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243223     DOI: 10.1016/j.pediatrneurol.2005.05.024

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  9 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; James D Katz; Olcay Y Jones
Journal:  Rheum Dis Clin North Am       Date:  2013-09-19       Impact factor: 2.670

Review 3.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

Review 4.  Exposure to mercury and aluminum in early life: developmental vulnerability as a modifying factor in neurologic and immunologic effects.

Authors:  José G Dórea
Journal:  Int J Environ Res Public Health       Date:  2015-01-23       Impact factor: 3.390

5.  Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.

Authors:  Rati Chkheidze; Dennis K Burns; Charles L White; Diana Castro; Julie Fuller; Chunyu Cai
Journal:  J Neuropathol Exp Neurol       Date:  2017-04-01       Impact factor: 3.685

Review 6.  Inflammation and Autophagy: A Convergent Point between Autism Spectrum Disorder (ASD)-Related Genetic and Environmental Factors: Focus on Aluminum Adjuvants.

Authors:  Loïc Angrand; Jean-Daniel Masson; Alberto Rubio-Casillas; Marika Nosten-Bertrand; Guillemette Crépeaux
Journal:  Toxics       Date:  2022-08-31

7.  A polysaccharide isolated from Agaricus blazei Murill (ABP-AW1) as a potential Th1 immunity-stimulating adjuvant.

Authors:  Liran Cui; Yongxu Sun; Hao Xu; Huiyu Xu; Huan Cong; Jicheng Liu
Journal:  Oncol Lett       Date:  2013-07-23       Impact factor: 2.967

Review 8.  Novel adjuvants & delivery vehicles for vaccines development: a road ahead.

Authors:  Teena Mohan; Priyanka Verma; D Nageswara Rao
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

9.  Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.

Authors:  Hyunhee Kim; Ka Young Lim; Jeongwan Kang; Jin Woo Park; Sung-Hye Park
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.